Rockefeller Capital Management
ABCL icon

Rockefeller Capital Management’s AbCellera Biologics ABCL Stock Holding History

Rockefeller Capital Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.98K Hold
2,000
– – ﹤0.01% 4136
2025
Q4 		$6.84K Sell
2,000
-500
-20% -$2.23K ﹤0.01% 3956
2025
Q3 		$12.6K Buy
+2,500
New +$11K ﹤0.01% 3560
2023
Q1 		– Sell
-500
Closed -$5K – 1974
2022
Q4 		$5K Buy
+500
New +$5.78K ﹤0.01% 3303
2022
Q3 		– Sell
-500
Closed -$5K – 3834
2022
Q2 		$5K Sell
500
-135
-21% -$1.14K ﹤0.01% 3415
2022
Q1 		$6K Buy
635
+135
+27% +$1.28K ﹤0.01% 3252
2021
Q4 		$7K Hold
500
– – ﹤0.01% 3123
2021
Q3 		$10K Buy
+500
New +$8.84K ﹤0.01% 2874

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return